Pradaxa Lawsuit Loans
Since Pradaxa gained FDA approval in 2010, the blood thinning medication has been the subject of growing litigation over its life-threatening side effects. If you’ve already filed a claim against drug manufacturer Boehringer Ingelheim regarding Pradaxa-related injuries, you may still be waiting for your case to resolve. As many plaintiffs are quickly discovering, product liability cases can take many months – sometimes years – to finalize, leaving patients saddled with enormous medical bills in the interim. If this sounds familiar and you are in need of immediate financial help, a Pradaxa lawsuit loan may be a practical solution to your monetary troubles.
Can I file a Pradaxa lawsuit?
If you were prescribed Pradaxa (generic name: dabigatran etexilate mesylate) by your attending physician and suffered adverse side effects such as excessive gastrointestinal bleeding, heart attack, stroke or a brain hemorrhage, you may have grounds for legal action against drug maker Boehringer Ingelheim. An attorney who is well-versed in personal injury and product liability litigation will determine your eligibility for filing a Pradaxa lawsuit. Plaintiffs who pursue legal recourse charge Pradaxa manufacturer with failing to warn of the serious health risks associated with its medication.
Approved for the treatment of non-valvular atrial fibrillation (AF), Pradaxa entered the U.S. marketplace on October 19, 2010. At the time, the only other drug available for AF patients was Coumadin (warfarin), which requires strict dietary restrictions and regular blood tests. Pradaxa manufacturers promoted their drug as an easy alternative to warfarin, since it doesn’t call for constant medical monitoring or dietary constraints. To date, the anticoagulant has been linked to numerous severe bleeding events and associated deaths, as Pradaxa has no known antidote to counteract excessive bleeding.
Reported side effects of Pradaxa
Similar to other blood thinning medications, Pradaxa carries the risk of serious side effects. While common complaints include gastrointestinal problems, some patients who take the drug experience uncontrollable bleeding. The following is a list of reported side effects linked to the ingestion of dabigatran, sold under the brand name of Pradaxa.
- Dark urine
- Bleeding from gums
- Severe headache
- Bloody or tarry stools
- Gastrointestinal upset
- Increased risk of heart attack
- Brain hemorrhage
- Joint swelling and/or pain
- Excessive internal bleeding
- Sudden death
FDA warning and documented Pradaxa risks
The FDA MedWatch report listed 542 Pradaxa-related deaths in 2011 – a staggering number when compared to fatalities linked to other medications. A recent study published in the Archives of Internal Medicine revealed that patients who took Pradaxa had a 33 percent higher risk of heart attack or heart disease than patients using other blood thinning drugs. On December 19, 2012, the FDA issued an urgent safety communication, advising the medical community that Pradaxa was not approved for reducing the risk of stroke in patients with atrial fibrillation caused by heart valves. The notice stated that health care providers should stop using Pradaxa in patients with heart valves as they were at a greater risk of suffering heart attacks and strokes and developing blood clots.
Federal Pradaxa lawsuits consolidated
In August of 2012, the Judicial Panel on Multidistrict Litigation (JPML) centralized all qualifying Pradaxa lawsuits into multidistrict litigation (MDL). The cases will be overseen by Honorable Judge David R. Herndon in the U.S. District Court for the Southern District of Illinois. The consolidated litigation brings together multiple cases involving similar allegations, namely that Pradaxa causes hemorrhages and other serious bleeding events. The Pradaxa MDL was created to help expedite pretrial proceedings, ultimately benefiting both plaintiffs and the defendant.
When can I expect compensation from my Pradaxa lawsuit?
If your pending case was transferred to the Pradaxa MDL in Illinois, Judge Herndon has asked both parties to discuss the possibility of Pradaxa lawsuit settlements prior to the first bellwether trial, which is slated to start in August, 2014. It is uncertain if Boehringer Ingelheim will negotiate settlements, or if cases will go to trial. Plaintiffs should be prepared for a potentially long battle in court, as favorable jury verdicts can be appealed. In this type of situation, Pradaxa lawsuit loans can help claimants tide over until their settlement or court award is dispersed. Litigation loans are an easy and effective means to help you get cash now, while you wait for your lawsuit to settle.
How can Pradaxa lawsuit loans help me?
Also known as settlement advance loans, these funds can be a true lifesaver when extended litigation threatens plaintiffs with bankruptcy or foreclosure on their home. Although it’s called a “loan,” this type of funding is really an emergency cash advance, designed to help the plaintiff cover daily living expenses, pay for medical bills and make rent or mortgage payments while awaiting a lawsuit settlement or verdict. With the help of LawStreet Capital’s Pradaxa lawsuit loans, claimants are no longer forced into accepting low-ball offers from insurance companies who often try and settle for as little as possible.
One of the best aspects of drug lawsuit loans is that they are completely risk free. If you don’t win or settle your Pradaxa case, you’ll owe nothing. And once approved, you can have cash in hand – from $500 to upwards of $100,000 – in just 24 hours.
Apply now for a pre settlement loan
Pradaxa lawsuit loans with LawStreet Capital are offered on a non-recourse basis. If you don’t receive compensation for your case, we don’t either. It’s just that simple. As a direct lender, we’re proud to offer the industry’s most competitive interest rates, and there are never any upfront fees, credit checks or employment verifications. Please call our helpful representatives today to start your free application. We’re here to help you every step of the way. Call us toll-free: 800-345-8500.